US to share 80 Million COVID-19 vaccines: United States President Joe Biden on Monday announced that the country is making a commitment to donate US-authorised 80 million doses of vaccine doses to struggling countries. The country will send at least 20 million more Pfizer, Moderna and Johnson & Johnson, in addition to 60 million AstraZeneca doses it had already planned to distribute in other countries in need. These vaccine doses will ship out to other countries by the end of June.
Taking to Twitter, Biden wrote that America will never be "fully safe" while this pandemic is still bringing destruction in other countries. The US President further added that this initiative is to reclaim "American leadership" in the global fight against the pandemic. "That’s why today, I’m announcing that over the next six weeks we will send 80 million vaccine doses overseas," he tweeted.
US President Joe Biden in a tweet announced that over the next six weeks they will be sending 80 million vaccine doses overseas, in view of COVID-19 pandemic. pic.twitter.com/LrnBZTAEfV— ANI (@ANI) May 17, 2021
"It is the right thing to do. It is the smart thing to do. It is the strong thing to do," Biden told reporters at a news conference. "This will be more vaccine doses than any country has actually shared to date, five times more than any other country. More than Russia and China, which have donated 15 million doses," he added.
Welcoming this move, the head of the World Health Organization hailed Biden and wrote, "Your commitment to global health is deeply appreciated!"
I welcome @POTUS & 🇺🇸's commitment to donate 80M #COVID19 vaccine doses to countries in need. Your commitment to global health is deeply appreciated! #COVAX partners stand ready to support equitable distribution. Solidarity is the only way to save lives & livelihoods everywhere. https://t.co/vep8m7aR51— Tedros Adhanom Ghebreyesus (@DrTedros) May 17, 2021
In a recent lab-based study carried out by US scientists, it was found that the Pfizer and Moderna COVID-19 vaccines remain effective against two coronavirus variants first identified in India. "What we found is that the vaccine's antibodies are a little bit weaker against the variants," said a senior author Nathaniel "Ned" Landau to AFP on Monday, but according to him the preliminary study is not enough to confirm that it would have much of an effect on the protective ability of the vaccines.
Meanwhile, the COVID-19 tally in India rose to 2,49,65,463 on Monday, May 17, with 2,81,386 fresh cases, the lowest in 27 days. The death count, however, climbed to 2,74,390 as 4,106 more people succumbed to the disease, according to Union Health Ministry data.
India is putting a strong fight against COVID-19! The #COVID19 recoveries are improving day by day. We all need to ensure that we follow COVID-appropriate behaviour at all times. #IndiaFightsCorona #MaskUpIndia@PMOIndia @MoHFW_INDIA @drharshvardhan @PIB_India @MIB_India pic.twitter.com/fkg08WQmwB— MyGovIndia (@mygovindia) May 17, 2021
Feature Image Credit: Republic TV